Cidecin

daptomycin · Cubist Pharmaceuticals LLC (a subsidiary of Merck & Co.)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cidecin, covering 2019-11-14 to 2019-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia [Phase 3]

See pricing